Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 69,113 | 25,591 | 81,406 | 80,748 | 111,108 |
| Cost of Goods | N/A | N/A | N/A | N/A | 24,519 |
| Gross Profit | 69,113 | 50,110 | 81,406 | 80,748 | 86,589 |
| Operating Expenses | 36,725 | -25,770 | 67,897 | 50,122 | 42,987 |
| Operating Income | 32,388 | 51,361 | 13,509 | 30,626 | 44,121 |
| Interest Expense | 18,274 | 9,013 | 23,102 | 23,209 | 23,850 |
| Other Income | -246 | 224 | -380 | -119 | -38 |
| Pre-tax Income | 13,868 | 42,572 | -9,973 | 7,298 | 20,233 |
| Income Tax | 1,199 | 7,371 | -4,830 | 583 | 1,659 |
| Net Income Continuous | 12,669 | 35,201 | -5,143 | 6,715 | 18,574 |
| Net Income Discontinuous | -13,999 | -22,479 | -636 | -1,221 | N/A |
| Net Income | $-1,330 | $12,722 | $-5,779 | $5,494 | $18,574 |
| EPS Basic Total Ops | -0.20 | 0.64 | -0.46 | 0.19 | 0.88 |
| EPS Basic Continuous Ops | 0.60 | 1.78 | -0.42 | 0.26 | 1.00 |
| EPS Basic Discontinuous Ops | -0.80 | -1.26 | -0.04 | -0.07 | N/A |
| EPS Diluted Total Ops | -0.20 | 0.64 | -0.46 | 0.18 | 0.87 |
| EPS Diluted Continuous Ops | 0.59 | 1.77 | -0.42 | 0.25 | 0.98 |
| EPS Diluted Discontinuous Ops | -0.79 | -1.24 | -0.04 | -0.07 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.67 | 0.54 | N/A | N/A | N/A |
| EBITDA(a) | $60,540 | $74,166 | $42,735 | $61,199 | $77,565 |